MyAverix Finance
AU · Healthcare
Inhalerx Ltd (IRX)
Biotechnology
Inhalerx Ltd (IRX) is listed on AU in the Healthcare sector. Industry: Biotechnology. As of 2026-05-23, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for IRX
Inhalerx Ltd (IRX) — FAQ
What is IRX's P/E ratio?
The price-to-earnings (P/E) ratio for Inhalerx Ltd (IRX) is 25.00 (data as of 2026-05-23).
Does Inhalerx Ltd pay a dividend?
Dividend yield is not available in the current snapshot for Inhalerx Ltd (IRX). Check the MyAverix Finance app for the latest dividend data.
What sector is Inhalerx Ltd in?
Inhalerx Ltd (IRX) is classified in the Healthcare sector (Biotechnology industry).
What exchange is IRX listed on?
IRX is listed on AU.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.